Epidemiology and molecular genetics of colorectal cancer.

[1]  J. Hecht.  Metastasis in colorectal cancer: what makes the tumor aggressive? , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[2]  J. Potter,et al.  Colorectal cancer: molecules and populations. , 1999, Journal of the National Cancer Institute.

[3]  John Calvin Reed,et al.  Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers. , 1999, Cancer research.

[4]  C. la Vecchia,et al.  Interaction between selected environmental factors and familial propensity for colon cancer. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[5]  Raymond L. White,et al.  Regulation of β-Catenin Signaling by the B56 Subunit of Protein Phosphatase 2A , 1999 .

[6]  Bandaru S. Reddy,et al.  Role of dietary fiber in colon cancer: an overview. , 1999, The American journal of medicine.

[7]  E. P. Kennedy,et al.  Genetics of colorectal cancer. , 1998, Seminars in surgical oncology.

[8]  T. Sugimura,et al.  Genetic determinant and environmental carcinogens. , 1998, Mutation research.

[9]  R. Bold,et al.  Apoptosis, cancer and cancer therapy. , 1997, Surgical oncology.

[10]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[11]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[12]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Der,et al.  Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Peifer.  Regulating Cell Proliferation--As Easy as APC , 1996, Science.

[15]  L. Ellis,et al.  Molecular determinants in the biology of liver metastasis. , 1996, Surgical oncology clinics of North America.

[16]  H. Lynch,et al.  Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome) , 1996, International journal of cancer.

[17]  John Calvin Reed.  Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. , 1995, Current opinion in oncology.

[18]  E. Fearon.  Molecular Genetics of Colorectal Cancer , 1995, Annals of the New York Academy of Sciences.

[19]  T. Noda,et al.  Subcellular localization of the APC protein: immunoelectron microscopic study of the association of the APC protein with catenin. , 1995, Oncogene.

[20]  Y. Nakamura,et al.  Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC) , 1995, Human molecular genetics.

[21]  V. Lazar,et al.  Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. , 1994, Human molecular genetics.

[22]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[23]  L. Loeb.  Microsatellite Instability: Marker of a Mutator Phenotype in Cancer , 1994 .

[24]  K. Kinzler,et al.  hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. , 1994, Cancer research.

[25]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[26]  Z. F. Liu,et al.  Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.

[27]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[28]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[29]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[30]  E. Kaplan,et al.  K-ras mutations in putative preneoplastic lesions in human colon. , 1993, Journal of the National Cancer Institute.

[31]  M. Hollstein,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.

[32]  B. Zetter,et al.  Adhesion molecules in tumor metastasis. , 1993, Seminars in cancer biology.

[33]  G. Capellá,et al.  Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. , 1993, Journal of the National Cancer Institute.

[34]  L. Roncucci,et al.  Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6‐year experience of a population‐based registry , 1993, Cancer.

[35]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[36]  L. Feig.  The many roads that lead to Ras. , 1993, Science.

[37]  S. Shirasawa,et al.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. , 1993, Science.

[38]  K. Kinzler,et al.  The APC gene product in normal and tumor cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Kathleen R. Cho,et al.  Genetic alterations in the adenoma–carcinoma sequence , 1992, Cancer.

[40]  J. Kere,et al.  Evidence that the MCC-APC gene region in 5q21 is not the site for susceptibility to hereditary nonpolyposis colorectal carcinoma. , 1992, Cancer research.

[41]  J. Fraumeni,et al.  Follow-up study of twenty-four families with Li-Fraumeni syndrome. , 1991, Cancer research.

[42]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[43]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[44]  M. Oshimura,et al.  Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18 , 1991, Nature.

[45]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[46]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[47]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[48]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[49]  H. J. Evans,et al.  High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. , 1989, Oncogene.

[50]  K. Sugio,et al.  Loss of constitutional heterozygosity in colorectal tumors from patients with familial polyposis coli and those with nonpolyposis colorectal carcinoma. , 1989, Cancer research.

[51]  A. Feinberg,et al.  MULTIPLE GENETIC ALTERATIONS IN DISTAL AND PROXIMAL COLORECTAL CANCER , 1989, The Lancet.

[52]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[53]  C. Marshall,et al.  A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. , 1988, Oncogene.

[54]  T. Smyrk,et al.  Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. , 1988, Gastroenterology clinics of North America.

[55]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[56]  G. Bolis.  Randomised comparison of cisplatin with Cyclophosphamide/Cisplatin and with Cyclophosphamide/Doxorubicin/Cisplatin in advanced ovarian cancer , 1988 .

[57]  Y. Nakamura,et al.  The gene for familial polyposis coli maps to the long arm of chromosome 5. , 1987, Science.

[58]  J. Mecklin.  Frequency of hereditary colorectal carcinoma. , 1987, Gastroenterology.

[59]  W. Cavenee,et al.  Genetics of cancer predisposition. , 1987, Cancer research.

[60]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.

[61]  I. Herskowitz.  Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[62]  F. C. Lucibello,et al.  Localization of the gene for familial adenomatous polyposis on chromosome 5 , 1987, Nature.

[63]  A. Sandberg,et al.  Gardner syndrome in a man with an interstitial deletion of 5q. , 1986, American journal of medical genetics.

[64]  R. Elston,et al.  Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource , 1985, Cancer.

[65]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[66]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[67]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[68]  L. Aaltonen,et al.  A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. , 1994, Cancer detection and prevention.

[69]  D. Wynford‐Thomas,et al.  In vitro transformation of epithelial cells by ras oncogenes. , 1993, Epithelial cell biology.

[70]  William E. Grizzle,et al.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis , 1987, Nature.

[71]  B. Vogelstein,et al.  Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.